Mapping the spike protein for vaccine development

Mapping the spike protein for vaccine development

Although the Covid-19 pandemic was the first time much of humanity learned of the now infamous disease, the family of coronaviruses was first identified in the mid-1960s. In a new study, molecular biologist Steven Van Doren, a scientist at the University of Missouri College of Agriculture, Food and Natural Resources, has uncovered the unexpected actions of a key player in how the coronavirus infects its target. His discovery could guide further vaccine development.

Funded by a National Science Foundation grant, Van Doren and his team studied the fusion peptide. This important feature of the spike protein serves to bind the virus with the human cell, an essential step in the course of infection. The study found that the fusion peptide plays a more invasive role in fusing the virus to the cell than previously thought, which is significant in understanding how infection occurs.

“The fusion peptide is the most preserved part of the whole viral spike,” says Van Doren, a professor of biochemistry. “Throughout the evolution of this virus, the fusion peptide endured despite all the mutations and variants that we kept on hearing about in the news. The fusion peptide never changed much and stayed a constant feature on the virus spike because it’s too critically important for infection for it to be modified.”

This research is interesting to compare to a recent study that surveyed asymptomatic patients infected by the coronavirus, who had developed a defence mechanism known as broadly neutralising antibodies. Van Doren’s research on the functionality of the fusion peptide’s ability to puncture a cell membrane could further inform why the fusion peptide may be an important target for vaccine development capable of fighting all types of coronavirus infections.

Another potential application of this research could be to create a novel strategy to penetrate cells. “There may be many strategies for crossing membranes, but it’s conceivable that the fusion peptide work could help further development of more ways to cross cellular membranes, which could be useful to deliver therapeutics through cell membranes,” notes Van Doren.

Further, this research broadens our understanding of protein insertion in membranes, which has broader relevance to the scientific community.

“I love what protein molecules look like and what they can do,” Van Doren said. “I got fascinated by the science when I was still a teenager, and it’s intriguing to me the things they can do, so studying how proteins work has been something that has stuck with me for decades now – I’d say going on almost 40 years.”

The study, “SARS-CoV-2 Fusion Peptide Sculpting of a Membrane with Insertion of Charged and Polar Groups” was published in Structure.

Published by

SHEQ Management

SHEQ MANAGEMENT is the definitive source for reliable, accurate and pertinent information to guarantee environmental health and safety in the workplace.
Prev Legal developments may have ripple effect 
Next Eco-friendly coffee from Colombia 

Leave a comment

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.